Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
CDHR1,Cadherin-related family member 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,9,1.06 [0.96-1.16],0.237738054000292,cis
CDHR1,Cadherin-related family member 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_CA_MET,Inverse variance weighted,4,1.34 [0.79-2.27],0.272765094403948,cis
CDHR1,Cadherin-related family member 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,9,1.05 [0.95-1.17],0.35010857288575,cis
CDHR1,Cadherin-related family member 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,9,1.02 [0.97-1.08],0.44726063871991,cis
CDHR1,Cadherin-related family member 1,Chapter II Neoplasms,CD2_BENIGN_ENDOCRINE_OTH,Inverse variance weighted,9,1 [0.88-1.14],0.978292284008003,cis
CDHR1,Cadherin-related family member 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,19,1.06 [0.99-1.14],0.107406906730231,trans
CDHR1,Cadherin-related family member 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,19,1.1 [0.96-1.27],0.155352955404385,trans
CDHR1,Cadherin-related family member 1,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,19,1.09 [0.94-1.26],0.238585606859187,trans
CDHR1,Cadherin-related family member 1,Chapter II Neoplasms,CD2_BENIGN_ENDOCRINE_OTH,Inverse variance weighted,19,1.01 [0.91-1.13],0.82269321189252,trans
